The global initiative for neonatal tetanus elimination was launched in 1989 following the unacceptably high neonatal morbidity and mortality from tetanus. Since then tremendous progress has been made evidenced with a 94% reduction in mortality. Despite this impressive progress, two global target dates have been missed, the latest being in 2005; which led to a further target of 2015 as the global neonatal tetanus elimination date. This target date has probably been missed again as there are still 21 countries yet to be validated. Nigeria is one such country and contributes two-thirds of the burden of neonatal tetanus globally. What are the prospects and challenges of neonatal tetanus elimination in Nigeria? This paper discusses these and other relevant issues regarding neonatal tetanus elimination and sustaining clearance.
Introduction
Neonatal tetanus refers to the disease occurring in a newborn from the 3rd to 28th day of life and contributes about 80% of the global tetanus disease burden. [1] [2] [3] It is a major cause of neonatal mortality and morbidity in low-and middle-income countries (LMICs). 4 The case fatality rate is 70-100% without treatment and 10-60% with hospital care, this being dependent on the availability of intensive care facilities and expertise. 2, 5, 6 Neonatal tetanus is highly preventable and is most frequently found in countries without a welldefined vaccination programme and where there is limited access to healthcare services and/or education. 1 It is often called the invisible killer because most deaths occur at home shortly after home delivery and such cases are not reported; consequently, cases are underreported in LMICs. 1, 7 The risk factors for the development of neonatal tetanus are well documented and are related to unhygienic childbirth practices and cord care, lack of skilled birth attendants, parental illiteracy, lack of antenatal care (ANC), lack of maternal immunisation against tetanus, geographical location and climate, settled rural agricultural populations, the prevalence of spores and seasonality. [7] [8] [9] [10] In the early 1980s, neonatal tetanus was estimated to cause over 500,000 neonatal deaths globally, increasing by 1988 to approximately 787,000.
2,5,11,13 Neonatal tetanus was then identified as a global health problem by the World Health Organization (WHO). It noted that such deaths could be prevented with changes in traditional obstetric practices and maternal immunisation, as neonatal tetanus had virtually disappeared in most of Europe and North America through hygienic childbirth practices and cord care. 5, 7, 14 The development of the tetanus vaccine markedly decreased the incidence in developed countries and also opened the door for reduction in LMICs.
In 1989, the WHO launched the initiative calling for the elimination of neonatal tetanus by 1995. The following year, the 1990 World Summit for Children included the same as one of its goals and this was again endorsed in 1991. The goal was to reduce neonatal tetanus cases to <1/1000 live births in every district of every country in order that neonatal tetanus will no longer be a major public health problem. access to information including safe delivery practices and healthcare. 2 Current estimates suggest that neonatal tetanus mortality has been reducing. In 1998, neonatal tetanus caused 215,000 (14%) of all neonatal deaths. 6 This figure dropped to 130,000 in 2004 but rose again in 2008 to 180,000. 5 It dropped again to 58,000 in 2010 and further to 49,000 in 2013. 12, 15 This represents a 94% mortality reduction from the 1980s. 12 As of September 2015, 21 countries though were yet to eliminate the disease.
Despite this impressive progress, three global elimination targets have been missed, most recently in 2005; leading to a further postponing to 2015 as the global neonatal tetanus elimination date. Neonatal tetanus, however, is still a substantial cause of mortality in many LMICs. Sustained emphasis on improvement of vaccination coverage, birth hygiene and surveillance, with specific approaches in high-risk areas, has meant that the incidence of the disease continues to fall. However, this has not been the case in Nigeria.
Strategies for elimination
The neonatal tetanus elimination initiative recommends a three-pronged approach: promotion of routine immunisation of pregnant women with tetanus toxoid (TT); promotion of clean deliveries; and surveillance of neonatal tetanus. 12 In high-risk areas, supplemental immunisation activities (SIAs) through immunisation campaigns are recommended. 5, 14 These involve targeted vaccination of women with little or no previous tetanus vaccinations.
Strengthening and promotion of routine immunisation, however, is the cornerstone of tetanus elimination. The vaccine is an inactivated toxin (toxoid) produced by Clostridium tetani. First produced in 1924, it became commercially available in 1938. 5, 16 It is affordable and cost-effective. TT was first combined with diphtheria and pertussis vaccines as DTP triple vaccine in 1940 and more recently Hemophilus type b and Hepatitis B vaccines were added as a Pentavalent vaccine used in many childhood immunisation programmes. 5 TT may also be given alone. A clinical trial in Papua New Guinea demonstrated that the use of two or more doses of TT during pregnancy was protective. 17 Based on this finding, the WHO introduced TT vaccination of pregnant women into its Expanded Program on Immunization. 5, 14 The lowest concentrations of tetanus anti-toxin considered as protective is 0.1-0.15 IU/mL, measured using ELISA. 5 Six months after receiving the second dose of TT, 90% of adults attain this protective level. 5 Despite immunity waning with time, about 75% of women or more maintain protective levels for three years. A third dose, given 6-12 months after the second dose or during the next pregnancy, increases both the neutralizing IgG antibody titre and the length of protective cover to five years, offering an immunity level of 95%. Fourth and fifth doses, given at intervals of one year, increase the degree of protection further to 99% and the duration of immunity to at least 20 years (Table 1) . 5, 18 TT is actively transported across the placenta to the fetus, giving passive protection during the first three months of infancy. Antibody titres of the mother and neonate at the time of delivery are usually similar. 5, 18 However, placental antibody transfer may decrease in the presence of maternal malaria and HIV infections. 19, 20 Elimination of neonatal tetanus in high-risk districts will require the use of SIAs in addition to routine immunisation services. 1 Using this approach, at least three properly spaced rounds of TT must be given, to at least 80% of women of childbearing age.
1 After 5-7 years, if routine tetanus vaccination of women is not provided, an increased number of women susceptible to tetanus will occur, requiring another campaign. This would usually target women aged 15-22 years. 1 Women with limited access to routine TT vaccinations or ANC usually have limited access to clean delivery. 1 Public health education and campaigns to underscore the necessity of ANC, hygienic practices during and after birth should be the focus together with vaccination. Clean delivery must include aseptic techniques: scrubbing of hands with soap and water, using clean surfaces and using clean instruments to cut the cord, using clean gloves and discouraging harmful traditional practices.
Surveillance is an essential component of elimination. Ideally, all health facilities should report neonatal tetanus cases monthly to the appropriate 2 At least 4 weeks after TT 1 80% 3 years TT 3 At least 6 months after TT 2 or during next pregnancy 95% 5 years TT 4 At least 1 year after TT 3 or during the next pregnancy 99% 10 years TT 5 At least 1 year after TT4 or during next pregnancy 99% 20 years authorities at every level. All such cases should be investigated further. 1 Any reported proven case of neonatal tetanus should prompt conducting SIAs. The WHO recommends that this should continue until ! 80% TT coverage (for pregnant women or all women of childbearing age) or 70% clean delivery protection is achieved. Then a case response system should be established whereby any case of neonatal tetanus leads to immunisation of all women of childbearing age in the community. 1 The WHO and UNICEF has recommended community-based surveillance, where feasible.
Endemic countries
Neonatal tetanus still remains endemic in 21 countries, including South Sudan.
2,5
Nigeria, despite being a signatory to the 1989 WHA Resolution to eliminate neonatal tetanus, still accounts for two-thirds of global neonatal tetanus cases. 21 The proportion of neonates at risk is 1:10 or 10 million neonates; about 300,000 in every state. 21 Currently, 50% of local government areas in Nigeria are at high risk ( Table 2) .
In 2013, only 53% of pregnant women received TT, with 38% of these being attended by birth attendants in health facilities. 22 In the rural areas, 89% of deliveries occur at home in unhygienic conditions without skilled attendants. 21 By zones, only the south-east and south-west attained 80% of births attended by skilled attendants in 2011 (Figure 1) . 21 ANC attendance and TT2 coverage has continued to falter over the years, decreasing from 49% in 2012 to 35% in 2014 (Tables 3 and 4) . 21, 23, 24 LGA, Local government area. 
Challenges in elimination
The prospects of neonatal tetanus elimination are high, but the challenges are enormous, requiring total commitment and focused strategies. These challenges include:
1. Ignorance, as most rural and urban dwellers are ignorant of the disease and methods of prevention; 2. Lack of quality ANC services in rural areas, which hinders significantly the proportion of pregnancies protected against tetanus. This is demonstrated by 60% ANC attendance in 2012 and 53% in 2013; 23 3. Relative lack of skilled birth attendants; these ensure clean aseptic practice. Skilled birth attendance has been faltering in Nigeria, as mentioned above; 4. Limited immunisation is clearly another reason and results from lack of funding and political will. Other rarer causes include difficult terrain, invisible women, limited information, limited immunization days, terrorism, attitudes of immunisation staff, fear of adverse reactions and misconceptions about vaccination. [25] [26] [27] In spite of its immense contribution to child survival, immunisation coverage has continued to vary in Nigeria. DPT3 coverage was 12%, 36%, 71% and 41% in 2003, 2006, 2009 and 2012, respectively; 23,25,28,29 5. Poor surveillance, as most health workers are unaware that neonatal tetanus is a reportable or notifiable disease;
6. Multicultural diversity in child birth practices and cord care, which are sensitive subjects and difficult to discourage if tied to tribal customs and religious beliefs.
Way forward
A massive but sustained public health education campaign is needed if the aim is to eliminate tetanus. This must describe what neonatal tetanus is, how it is contracted, the symptoms of lock jaw, spasms and rigidity with or without fever, the available treatment options, the preventive measures, the role of maternal TT in preventing the disease, clean severance of the cord and optimal cord care. The importance of public enlightenment cannot be overemphasised as it is the key to community mobilisation, acceptance and participation.
Immunisation coverage must be improved through strengthening of routine immunisation programmes, campaign immunisations and establishment of schoolbased immunisation. 30 SIAs lead to increased immunisation coverage, reduced disease spread and cost-effectiveness. 31 TT can also be tagged on other national immunisation efforts such as the polio eradication initiative. Strengthening of routine immunisation will entail political will to own and provide vaccines, maintenance of cold chain and provision of immunisation services 24 h of the day at every health facility. Establishment of a school-based immunisation programme will enable young girls to complete the five dose regimen of TT.
There is an urgent need to raise ANC attendance in Nigeria. Currently, <20% of health facilities in Nigeria offer emergency obstetric care and only 35% of deliveries are attended by skilled birth attendants. 23 Appropriate surveillance is also an imperative.
Lastly, the rural community and other programmes of the National Health Insurance Scheme (NHIS) should be implemented. 32 Free ANC and deliveries in health institutions provided by the NHIS will encourage rural dwellers to access ANC services including TT and antimalarial prophylaxis. It will also increase the number of births attended by skilled birth attendants and institutional deliveries.
Conclusion
Neonatal tetanus contributes significantly to neonatal morbidity and mortality in many countries. Case fatality is very high with or without medical care. However, it is highly preventable. Currently, Nigeria contributes about two third of the global neonatal tetanus cases. Using a three pronged approach, neonatal tetanus can be eliminated via promotion of hygienic practices during delivery, strengthening maternal and childhood immunization, and close surveillance. Although significant inroads have been made toward eliminating neonatal tetanus, the goal has yet to be achieved. The prospects for neonatal tetanus elimination in Nigeria are high but the current challenges require urgent, sustained and focused attention so as to shorten the journey from now to elimination time.
